A prospective study of 447 food-allergic infants reports a cost-sensitive ensemble model that predicts school-age asthma with ...
Children aged 6-11 years with moderate-to-severe asthma with type 2 inflammation who were treated with dupilumab were at least twice as likely to achieve clinical remission after 1 year compared to ...
A Shanghai time-series study of over 42,000 pediatric asthma emergency visits shows humid heat measured by Wet-Bulb Globe ...
In respiratory medicine, biomarkers can provide information that symptoms and conventional lung-function measurements cannot ...
China: Researchers have found in a 24-week subgroup analysis that dupilumab improved lung function, asthma control, and ...
Blue inhalers have been a staple for millions of people with asthma for decades - but new NICE guidelines mean that anyone ...
Type 2 inflammation targeting drugs are a group of pharmaceutical products that target immune pathways and signaling ...
"I have a cough that lasts for over a month after a cold," or "My asthma tends to get worse when flu and infectious disease ...
Symptoms of seasonal allergies and the common cold can overlap. Learn how to tell them apart so you can get the treatment you need.
The combined circulation of common respiratory viruses is a stronger indicator of seasonal hospital admissions than the ...
Objective To explore experiences and perceptions of financial incentives from children and young people (CYP) involved in the ...
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved in the European Union as a maintenance treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results